Report Detail
Global Cattle Vaccine Market 2026 by Company, Regions, Type and Application, Forecast to 2032
- RnM4663074 |
- 19 January, 2026 |
- Global |
- 106 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Cattle Vaccine market size was valued at US$ 1832 million in 2025 and is forecast to a readjusted size of US$ 2778 million by 2032 with a CAGR of 6.2% during review period.
A cattle vaccine is a biological preparation designed to help cattle (both beef and dairy) develop immunity against specific infectious diseases.
It contains weakened, killed, or inactivated pathogens (or parts of them, such as proteins or toxins) that stimulate the cow’s immune system to recognize and fight the disease without causing the disease itself. In 2024, global cattle vaccines production reached approximately 160 million units , with an average global market price of around US$ 10.5 per unit.
Global outbreaks of infectious bovine diseases—such as Foot-and-Mouth Disease (FMD), Bovine Respiratory Disease Complex (BRDC), Brucellosis, and Bovine Viral Diarrhea (BVD)—are increasing vaccination adoption rates. These diseases can cause massive productivity and economic losses in the livestock industry, making preventive vaccination an essential part of herd management.
Increasing demand for high-quality beef and dairy products, especially in Asia-Pacific and Latin America, is pushing farmers to invest in vaccines to maintain herd productivity and product safety.
Many regions (e.g., EU, parts of South America, India) implement government-subsidized or mandatory cattle vaccination programs to control endemic diseases, ensuring market stability.
Development of recombinant DNA vaccines, subunit vaccines, and mRNA-based veterinary vaccines is accelerating, improving efficacy and reducing adverse reactions.
Multi-disease vaccines are gaining popularity for reducing labor costs and stress on animals during administration.
Especially important for developing countries, thermostable vaccines reduce dependency on cold chain logistics.
This report is a detailed and comprehensive analysis for global Cattle Vaccine market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Sales Channel. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Cattle Vaccine market size and forecasts, in consumption value ($ Million), 2021-2032
Global Cattle Vaccine market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Cattle Vaccine market size and forecasts, by Type and by Sales Channel, in consumption value ($ Million), 2021-2032
Global Cattle Vaccine market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cattle Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cattle Vaccine market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck Animal Health, Zoetis, Boehringer Ingelheim, Ceva, Zoetis, Elanco Animal Health, Indian Immunologicals, Cambridge Technologies, Vaxxinova, Jinyu Bio-Technolog, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Cattle Vaccine market is split by Type and by Sales Channel. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Sales Channel. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Live Attenuated Vaccine
Inactivated Vaccine
Others
Market segment by Sales Channel
Government Bidding
Market Sales
Market segment by players, this report covers
Merck Animal Health
Zoetis
Boehringer Ingelheim
Ceva
Zoetis
Elanco Animal Health
Indian Immunologicals
Cambridge Technologies
Vaxxinova
Jinyu Bio-Technolog
China Animal Husbandry Industry
Tecon Biology
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cattle Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cattle Vaccine, with revenue, gross margin, and global market share of Cattle Vaccine from 2021 to 2026.
Chapter 3, the Cattle Vaccine competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Sales Channel, with consumption value and growth rate by Type, by Sales Channel, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Cattle Vaccine market forecast, by regions, by Type and by Sales Channel, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cattle Vaccine.
Chapter 13, to describe Cattle Vaccine research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Cattle Vaccine by Type
- 1.3.1 Overview: Global Cattle Vaccine Market Size by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Global Cattle Vaccine Consumption Value Market Share by Type in 2025
- 1.3.3 Live Attenuated Vaccine
- 1.3.4 Inactivated Vaccine
- 1.3.5 Others
- 1.4 Global Cattle Vaccine Market by Sales Channel
- 1.4.1 Overview: Global Cattle Vaccine Market Size by Sales Channel: 2021 Versus 2025 Versus 2032
- 1.4.2 Government Bidding
- 1.4.3 Market Sales
- 1.5 Global Cattle Vaccine Market Size & Forecast
- 1.6 Global Cattle Vaccine Market Size and Forecast by Region
- 1.6.1 Global Cattle Vaccine Market Size by Region: 2021 VS 2025 VS 2032
- 1.6.2 Global Cattle Vaccine Market Size by Region, (2021-2032)
- 1.6.3 North America Cattle Vaccine Market Size and Prospect (2021-2032)
- 1.6.4 Europe Cattle Vaccine Market Size and Prospect (2021-2032)
- 1.6.5 Asia-Pacific Cattle Vaccine Market Size and Prospect (2021-2032)
- 1.6.6 South America Cattle Vaccine Market Size and Prospect (2021-2032)
- 1.6.7 Middle East & Africa Cattle Vaccine Market Size and Prospect (2021-2032)
2 Company Profiles
- 2.1 Merck Animal Health
- 2.1.1 Merck Animal Health Details
- 2.1.2 Merck Animal Health Major Business
- 2.1.3 Merck Animal Health Cattle Vaccine Product and Solutions
- 2.1.4 Merck Animal Health Cattle Vaccine Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Merck Animal Health Recent Developments and Future Plans
- 2.2 Zoetis
- 2.2.1 Zoetis Details
- 2.2.2 Zoetis Major Business
- 2.2.3 Zoetis Cattle Vaccine Product and Solutions
- 2.2.4 Zoetis Cattle Vaccine Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Zoetis Recent Developments and Future Plans
- 2.3 Boehringer Ingelheim
- 2.3.1 Boehringer Ingelheim Details
- 2.3.2 Boehringer Ingelheim Major Business
- 2.3.3 Boehringer Ingelheim Cattle Vaccine Product and Solutions
- 2.3.4 Boehringer Ingelheim Cattle Vaccine Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Boehringer Ingelheim Recent Developments and Future Plans
- 2.4 Ceva
- 2.4.1 Ceva Details
- 2.4.2 Ceva Major Business
- 2.4.3 Ceva Cattle Vaccine Product and Solutions
- 2.4.4 Ceva Cattle Vaccine Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Ceva Recent Developments and Future Plans
- 2.5 Zoetis
- 2.5.1 Zoetis Details
- 2.5.2 Zoetis Major Business
- 2.5.3 Zoetis Cattle Vaccine Product and Solutions
- 2.5.4 Zoetis Cattle Vaccine Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Zoetis Recent Developments and Future Plans
- 2.6 Elanco Animal Health
- 2.6.1 Elanco Animal Health Details
- 2.6.2 Elanco Animal Health Major Business
- 2.6.3 Elanco Animal Health Cattle Vaccine Product and Solutions
- 2.6.4 Elanco Animal Health Cattle Vaccine Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Elanco Animal Health Recent Developments and Future Plans
- 2.7 Indian Immunologicals
- 2.7.1 Indian Immunologicals Details
- 2.7.2 Indian Immunologicals Major Business
- 2.7.3 Indian Immunologicals Cattle Vaccine Product and Solutions
- 2.7.4 Indian Immunologicals Cattle Vaccine Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Indian Immunologicals Recent Developments and Future Plans
- 2.8 Cambridge Technologies
- 2.8.1 Cambridge Technologies Details
- 2.8.2 Cambridge Technologies Major Business
- 2.8.3 Cambridge Technologies Cattle Vaccine Product and Solutions
- 2.8.4 Cambridge Technologies Cattle Vaccine Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Cambridge Technologies Recent Developments and Future Plans
- 2.9 Vaxxinova
- 2.9.1 Vaxxinova Details
- 2.9.2 Vaxxinova Major Business
- 2.9.3 Vaxxinova Cattle Vaccine Product and Solutions
- 2.9.4 Vaxxinova Cattle Vaccine Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Vaxxinova Recent Developments and Future Plans
- 2.10 Jinyu Bio-Technolog
- 2.10.1 Jinyu Bio-Technolog Details
- 2.10.2 Jinyu Bio-Technolog Major Business
- 2.10.3 Jinyu Bio-Technolog Cattle Vaccine Product and Solutions
- 2.10.4 Jinyu Bio-Technolog Cattle Vaccine Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Jinyu Bio-Technolog Recent Developments and Future Plans
- 2.11 China Animal Husbandry Industry
- 2.11.1 China Animal Husbandry Industry Details
- 2.11.2 China Animal Husbandry Industry Major Business
- 2.11.3 China Animal Husbandry Industry Cattle Vaccine Product and Solutions
- 2.11.4 China Animal Husbandry Industry Cattle Vaccine Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 China Animal Husbandry Industry Recent Developments and Future Plans
- 2.12 Tecon Biology
- 2.12.1 Tecon Biology Details
- 2.12.2 Tecon Biology Major Business
- 2.12.3 Tecon Biology Cattle Vaccine Product and Solutions
- 2.12.4 Tecon Biology Cattle Vaccine Revenue, Gross Margin and Market Share (2021-2026)
- 2.12.5 Tecon Biology Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Cattle Vaccine Revenue and Share by Players (2021-2026)
- 3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Cattle Vaccine by Company Revenue
- 3.2.2 Top 3 Cattle Vaccine Players Market Share in 2025
- 3.2.3 Top 6 Cattle Vaccine Players Market Share in 2025
- 3.3 Cattle Vaccine Market: Overall Company Footprint Analysis
- 3.3.1 Cattle Vaccine Market: Region Footprint
- 3.3.2 Cattle Vaccine Market: Company Product Type Footprint
- 3.3.3 Cattle Vaccine Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Cattle Vaccine Consumption Value and Market Share by Type (2021-2026)
- 4.2 Global Cattle Vaccine Market Forecast by Type (2027-2032)
5 Market Size Segment by Sales Channel
- 5.1 Global Cattle Vaccine Consumption Value Market Share by Sales Channel (2021-2026)
- 5.2 Global Cattle Vaccine Market Forecast by Sales Channel (2027-2032)
6 North America
- 6.1 North America Cattle Vaccine Consumption Value by Type (2021-2032)
- 6.2 North America Cattle Vaccine Market Size by Sales Channel (2021-2032)
- 6.3 North America Cattle Vaccine Market Size by Country
- 6.3.1 North America Cattle Vaccine Consumption Value by Country (2021-2032)
- 6.3.2 United States Cattle Vaccine Market Size and Forecast (2021-2032)
- 6.3.3 Canada Cattle Vaccine Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Cattle Vaccine Market Size and Forecast (2021-2032)
7 Europe
- 7.1 Europe Cattle Vaccine Consumption Value by Type (2021-2032)
- 7.2 Europe Cattle Vaccine Consumption Value by Sales Channel (2021-2032)
- 7.3 Europe Cattle Vaccine Market Size by Country
- 7.3.1 Europe Cattle Vaccine Consumption Value by Country (2021-2032)
- 7.3.2 Germany Cattle Vaccine Market Size and Forecast (2021-2032)
- 7.3.3 France Cattle Vaccine Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Cattle Vaccine Market Size and Forecast (2021-2032)
- 7.3.5 Russia Cattle Vaccine Market Size and Forecast (2021-2032)
- 7.3.6 Italy Cattle Vaccine Market Size and Forecast (2021-2032)
8 Asia-Pacific
- 8.1 Asia-Pacific Cattle Vaccine Consumption Value by Type (2021-2032)
- 8.2 Asia-Pacific Cattle Vaccine Consumption Value by Sales Channel (2021-2032)
- 8.3 Asia-Pacific Cattle Vaccine Market Size by Region
- 8.3.1 Asia-Pacific Cattle Vaccine Consumption Value by Region (2021-2032)
- 8.3.2 China Cattle Vaccine Market Size and Forecast (2021-2032)
- 8.3.3 Japan Cattle Vaccine Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Cattle Vaccine Market Size and Forecast (2021-2032)
- 8.3.5 India Cattle Vaccine Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Cattle Vaccine Market Size and Forecast (2021-2032)
- 8.3.7 Australia Cattle Vaccine Market Size and Forecast (2021-2032)
9 South America
- 9.1 South America Cattle Vaccine Consumption Value by Type (2021-2032)
- 9.2 South America Cattle Vaccine Consumption Value by Sales Channel (2021-2032)
- 9.3 South America Cattle Vaccine Market Size by Country
- 9.3.1 South America Cattle Vaccine Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Cattle Vaccine Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Cattle Vaccine Market Size and Forecast (2021-2032)
10 Middle East & Africa
- 10.1 Middle East & Africa Cattle Vaccine Consumption Value by Type (2021-2032)
- 10.2 Middle East & Africa Cattle Vaccine Consumption Value by Sales Channel (2021-2032)
- 10.3 Middle East & Africa Cattle Vaccine Market Size by Country
- 10.3.1 Middle East & Africa Cattle Vaccine Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Cattle Vaccine Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Cattle Vaccine Market Size and Forecast (2021-2032)
- 10.3.4 UAE Cattle Vaccine Market Size and Forecast (2021-2032)
11 Market Dynamics
- 11.1 Cattle Vaccine Market Drivers
- 11.2 Cattle Vaccine Market Restraints
- 11.3 Cattle Vaccine Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Cattle Vaccine Industry Chain
- 12.2 Cattle Vaccine Upstream Analysis
- 12.3 Cattle Vaccine Midstream Analysis
- 12.4 Cattle Vaccine Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Cattle Vaccine. Industry analysis & Market Report on Cattle Vaccine is a syndicated market report, published as Global Cattle Vaccine Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Cattle Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
